4//SEC Filing
COLLINS MORTON 4
Accession 0001055726-19-000034
CIK 0001055726other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 6:06 PM ET
Size
7.7 KB
Accession
0001055726-19-000034
Insider Transaction Report
Form 4
COLLINS MORTON
Director
Transactions
- Award
Restricted Stock Unit
2019-05-08+8,013→ 8,013 total→ Common Stock (8,013 underlying) - Award
Common Stock Options
2019-05-08+12,500→ 12,500 totalExercise: $3.90Exp: 2029-05-08→ Common Stock (12,500 underlying)
Footnotes (3)
- [F1]This grant was made pursuant to the issuer's non-employee director compensation policy.
- [F2]Options to vest with respect to 100% of the shares on May 8, 2020.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 8, 2020.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001238716
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 6:06 PM ET
- Size
- 7.7 KB